Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Easy-to-Use Kits Allow Rapid Identification of Microorganisms

By LabMedica International staff writers
Posted on 16 Mar 2009
Easy-to-use kits allow the accurate identification of a comprehensive range of microorganisms in just 4 hours, providing a faster and more convenient alternative to other commercially available methods.

The kit, RapID, was shown to perform significantly better than other leading commercially available systems, particularly in the identification of clinically significant yeasts and nonfermentative Gram-negative bacilli, including Burkholderia cepacia, an important pathogen in cystic fibrosis patients.

The RapID method detects preformed bacterial enzymes and is not dependent on the growth of the organism. More...
This feature allows the panels to be incubated aerobically without the need for oil overlays--resulting in further savings on time and resources.

RapID identification panels have a simple, one-step inoculation procedure. A suspect colony suspension is simply added to the inoculation tray and tipped into the test strip, inoculating each well simultaneously. Each RapID panel has the same simple procedure, allowing users to pick up the method easily without having to remember different procedures for different organism groups.

In one study RapID Yeast Plus performed significantly better than other systems in the identification of Candida krusei, which is an important pathogen of immunocompromised patients. Since this organism has an innate resistance to fluconazole, prompt identification is extremely important for appropriate therapy to be administered quickly.

In trials, the RapID method demonstrated excellent performance in the identification of oxidase negative Enterobacteriaceae, anaerobic bacteria, Gram-negative glucose non-fermenters, Corynebacterium species, yeasts, and streptococci, and related organisms. A new system is now available for the identification of staphylococci and related organisms.

The RapID systems are being offered by Oxoid (Basingstoke, UK). The RapID systems provide rapid, same-day results, compared to alternative methods that require 18-72 hours. In addition, the tests are not automated, thus allowing even smaller routine microbiology laboratories to adopt them easily.

Related Links:

Oxoid




New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Pathology

view channel
Image: Virtual staining of label-free tissue in imaging mass spectrometry (Photo courtesy of Ozcan Lab/UCLA)

Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. However, IMS is hindered by relatively low... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.